By Emily Kopp
The FBI is investigating a trio of children’s hospitals for allegedly and potentially violating a federal law against genital mutilation through the provision of pediatric sex change surgeries, according to a Fox News report.
The hospitals reportedly under FBI scrutiny for providing sex change surgeries and hormone replacement therapy include Boston Children’s Hospital, Children’s Hospital Colorado and Children’s Hospital Los Angeles.
Attorney General Pam Bondi instructed attorneys general in an April 22 memo to pursue cases against health providers under 18 U.S.C. § 116, a federal statute outlawing female genital mutilation on any person under the age of 18. The crime carries a maximum prison sentence of 10 years per count.
The memo also instructed the FBI to investigate violations of the False Claims Act connected to providers conducting transgender surgeries but billing Medicaid for another procedure.
Bondi also announced a Coalition Against Child Mutilation to coordinate with state attorneys general to build cases against hospitals and providers violating these laws. (RELATED: Hospital Scrubs Notorious Child Sex Change Clinic From Website As Gender Industrial Complex Goes In Full Retreat)
Bondi’s memo followed an executive order signed by President Donald Trump on Jan. 28 that instructed the attorney general to prioritize such cases.
“We applaud Attorney General Pam Bondi and the FBI for launching criminal investigations into these hospitals. Children’s hospitals should be places where sick children can receive high-quality and evidence-based care, not laboratories where activist doctors experiment on kids,” said Do No Harm Chair Stanley Goldfarb in a statement.
Do No Harm, a health care watchdog, identified the trio of hospitals reportedly under FBI scrutiny as among the dozen American hospitals with the highest volume of sex change-related treatments, surgeries and hormone and puberty blocker prescriptions in children. The group’s analysis found $119 million flowing to hospitals for sex change treatments for minors from 2019 to 2023.
When Children’s Hospital Los Angeles announced in February that it would cease transgender treatments, the move was challenged by California Attorney General Rob Bonta, who warned that the move could violate the state’s nondiscrimination laws.
Nonetheless, Children’s Hospital Los Angeles will permanently shutter the Center for Transyouth Health and Development in July. (RELATED: One Of America’s Biggest Youth Trans Clinics Closing Its Doors)
Children’s Hospital Colorado continues to provide puberty blockers and hormone treatments to minors but insists that the hospital “never” provided transgender surgeries for those under 18, instead making referrals to other providers, according to the Fox report.
Boston Children’s Hospital continues to operate its Gender Multispecialty Service program, according to its website. The hospital restricts surgeries to patients over 18 but offers minors hormone therapy, puberty blockers and external referrals for surgery, Fox reported.
A 2024 study in the Cureus Journal of Medical Science found that sex changes massively increase suicide risks, rather than reducing them.
95% of young transgender people on testosterone — a form of gender-affirming care — develop pelvic floor dysfunction; most have bowel issues and sexual dysfunction. The Telegraph newspaper reported that “87 per cent” of young transgender people on testosterone “had urinary symptoms such as incontinence, frequent toilet visits and bed-wetting, while 74 per cent had bowel issues including constipation or being unable to hold stools or wind in. Some 53 per cent suffered from sexual dysfunction…Almost half had an ‘orgasm disorder’, while a quarter suffered from pain during sexual intercourse.”
Even researchers who back “gender-affirming care” have admitted that it increases rather than reduces the risk of suicide. The FDA notes that puberty blockers can cause brain swelling and vision loss, and an FDA official who supported giving minors puberty blockers conceded that they actually increase suicidality. Indeed, the “FDA knew ‘gender affirming’ puberty blockers increase ‘suicidality’ in 2017,” reported Just the News.
The nation’s leading transgender lawyer defending gender transitions for minors — the ACLU’s Chase Strangio — conceded to the Supreme Court that “there is no evidence…that this treatment reduces completed suicide.”
